Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Malignant neoplasm of pancreas
|
277 | 0.487 | 0.760 | 19 | 45351661 | stop gained | T/A;G | snv | 4.0E-06; 0.32 | 0.060 | 0.833 | 6 | 2007 | 2019 | |||||
Pancreatic carcinoma
|
322 | 0.487 | 0.760 | 19 | 45351661 | stop gained | T/A;G | snv | 4.0E-06; 0.32 | 0.060 | 0.833 | 6 | 2007 | 2019 | |||||
Carcinoma, Ovarian Epithelial
|
327 | 0.487 | 0.760 | 19 | 45351661 | stop gained | T/A;G | snv | 4.0E-06; 0.32 | 0.050 | 0.600 | 5 | 2013 | 2017 | |||||
Liver carcinoma
|
942 | 0.487 | 0.760 | 19 | 45351661 | stop gained | T/A;G | snv | 4.0E-06; 0.32 | 0.050 | 1.000 | 5 | 2014 | 2019 | |||||
Nasopharyngeal carcinoma
|
320 | 0.487 | 0.760 | 19 | 45351661 | stop gained | T/A;G | snv | 4.0E-06; 0.32 | 0.050 | 0.800 | 5 | 2014 | 2018 | |||||
Head and Neck Carcinoma
|
118 | 0.487 | 0.760 | 19 | 45351661 | stop gained | T/A;G | snv | 4.0E-06; 0.32 | 0.040 | 0.500 | 4 | 2011 | 2014 | |||||
Lymphoma, Non-Hodgkin
|
197 | 0.487 | 0.760 | 19 | 45351661 | stop gained | T/A;G | snv | 4.0E-06; 0.32 | 0.040 | 0.750 | 4 | 2009 | 2015 | |||||
Malignant Head and Neck Neoplasm
|
118 | 0.487 | 0.760 | 19 | 45351661 | stop gained | T/A;G | snv | 4.0E-06; 0.32 | 0.040 | 0.500 | 4 | 2011 | 2014 | |||||
Malignant neoplasm of ovary
|
315 | 0.487 | 0.760 | 19 | 45351661 | stop gained | T/A;G | snv | 4.0E-06; 0.32 | 0.040 | 0.750 | 4 | 2013 | 2017 | |||||
ovarian neoplasm
|
757 | 0.487 | 0.760 | 19 | 45351661 | stop gained | T/A;G | snv | 4.0E-06; 0.32 | 0.040 | 0.750 | 4 | 2013 | 2017 | |||||
Squamous cell carcinoma of esophagus
|
329 | 0.487 | 0.760 | 19 | 45351661 | stop gained | T/A;G | snv | 4.0E-06; 0.32 | 0.040 | 1.000 | 4 | 2002 | 2012 | |||||
Adenocarcinoma Of Esophagus
|
81 | 0.487 | 0.760 | 19 | 45351661 | stop gained | T/A;G | snv | 4.0E-06; 0.32 | 0.030 | 1.000 | 3 | 2005 | 2008 | |||||
Carcinoma, Basal Cell
|
91 | 0.487 | 0.760 | 19 | 45351661 | stop gained | T/A;G | snv | 4.0E-06; 0.32 | 0.030 | 0.667 | 3 | 1999 | 2005 | |||||
Congenital chromosomal disease
|
47 | 0.487 | 0.760 | 19 | 45351661 | stop gained | T/A;G | snv | 4.0E-06; 0.32 | 0.030 | 1.000 | 3 | 2004 | 2012 | |||||
Cutaneous Melanoma
|
248 | 0.487 | 0.760 | 19 | 45351661 | stop gained | T/A;G | snv | 4.0E-06; 0.32 | 0.030 | 0.667 | 3 | 2013 | 2015 | |||||
Diffuse Large B-Cell Lymphoma
|
127 | 0.487 | 0.760 | 19 | 45351661 | stop gained | T/A;G | snv | 4.0E-06; 0.32 | 0.030 | 0.667 | 3 | 2013 | 2018 | |||||
Endometrial Carcinoma
|
326 | 0.487 | 0.760 | 19 | 45351661 | stop gained | T/A;G | snv | 4.0E-06; 0.32 | 0.030 | 1.000 | 3 | 2012 | 2014 | |||||
Experimental Organism Basal Cell Carcinoma
|
63 | 0.487 | 0.760 | 19 | 45351661 | stop gained | T/A;G | snv | 4.0E-06; 0.32 | 0.030 | 0.667 | 3 | 1999 | 2005 | |||||
Lip and Oral Cavity Carcinoma
|
172 | 0.487 | 0.760 | 19 | 45351661 | stop gained | T/A;G | snv | 4.0E-06; 0.32 | 0.030 | 0.333 | 3 | 2007 | 2013 | |||||
Malignant neoplasm of mouth
|
184 | 0.487 | 0.760 | 19 | 45351661 | stop gained | T/A;G | snv | 4.0E-06; 0.32 | 0.030 | 0.333 | 3 | 2007 | 2013 | |||||
Rectal Carcinoma
|
112 | 0.487 | 0.760 | 19 | 45351661 | stop gained | T/A;G | snv | 4.0E-06; 0.32 | 0.030 | 1.000 | 3 | 2009 | 2010 | |||||
Skin carcinoma
|
24 | 0.487 | 0.760 | 19 | 45351661 | stop gained | T/A;G | snv | 4.0E-06; 0.32 | 0.030 | 0.667 | 3 | 2004 | 2014 | |||||
Squamous cell carcinoma of the head and neck
|
348 | 0.487 | 0.760 | 19 | 45351661 | stop gained | T/A;G | snv | 4.0E-06; 0.32 | 0.030 | 1.000 | 3 | 2011 | 2017 | |||||
Acute monocytic leukemia
|
22 | 0.487 | 0.760 | 19 | 45351661 | stop gained | T/A;G | snv | 4.0E-06; 0.32 | 0.020 | 1.000 | 2 | 2006 | 2014 | |||||
Adult Non-Hodgkin Lymphoma
|
39 | 0.487 | 0.760 | 19 | 45351661 | stop gained | T/A;G | snv | 4.0E-06; 0.32 | 0.020 | 1.000 | 2 | 2014 | 2015 |